MEDIFAST INC
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. … Read more
MEDIFAST INC (MED) - Total Liabilities
Latest total liabilities as of September 2025: $53.50 Million USD
Based on the latest financial reports, MEDIFAST INC (MED) has total liabilities worth $53.50 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MEDIFAST INC - Total Liabilities Trend (1996–2024)
This chart illustrates how MEDIFAST INC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MEDIFAST INC Competitors by Total Liabilities
The table below lists competitors of MEDIFAST INC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IVF Hartmann Holding AG
SW:VBSN
|
Switzerland | CHF35.56 Million |
|
Mammoth Energy Services Inc
NASDAQ:TUSK
|
USA | $87.51 Million |
|
VERSES AI Inc.
OTCQX:VRSSF
|
USA | $27.58 Million |
|
CBO Territoria S.A.
PA:CBOT
|
France | €222.47 Million |
|
Kolte - Patil Developers Limited
NSE:KOLTEPATIL
|
India | ₹52.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩520.25 Billion |
|
GeoVision Inc
TW:3356
|
Taiwan | NT$671.87 Million |
|
Namyang Dairy Products Co Ltd Peffered Series 1
KO:003925
|
Korea | ₩99.16 Billion |
Liability Composition Analysis (1996–2024)
This chart breaks down MEDIFAST INC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.13 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MEDIFAST INC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MEDIFAST INC (1996–2024)
The table below shows the annual total liabilities of MEDIFAST INC from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $74.10 Million | -31.66% |
| 2023-12-31 | $108.43 Million | -32.72% |
| 2022-12-31 | $161.17 Million | -17.71% |
| 2021-12-31 | $195.85 Million | +64.81% |
| 2020-12-31 | $118.84 Million | +32.31% |
| 2019-12-31 | $89.82 Million | +48.90% |
| 2018-12-31 | $60.32 Million | +61.52% |
| 2017-12-31 | $37.35 Million | +48.21% |
| 2016-12-31 | $25.20 Million | -12.32% |
| 2015-12-31 | $28.74 Million | -18.89% |
| 2014-12-31 | $35.43 Million | +3.51% |
| 2013-12-31 | $34.23 Million | -13.25% |
| 2012-12-31 | $39.47 Million | +22.32% |
| 2011-12-31 | $32.26 Million | +45.97% |
| 2010-12-31 | $22.10 Million | +97.21% |
| 2009-12-31 | $11.21 Million | -12.87% |
| 2008-12-31 | $12.86 Million | +13.80% |
| 2007-12-31 | $11.30 Million | +29.03% |
| 2006-12-31 | $8.76 Million | +2.78% |
| 2005-12-31 | $8.52 Million | +26.06% |
| 2004-12-31 | $6.76 Million | -5.49% |
| 2003-12-31 | $7.16 Million | +66.01% |
| 2002-12-31 | $4.31 Million | +426.25% |
| 2001-12-31 | $819.00K | -57.23% |
| 2000-12-31 | $1.92 Million | -17.63% |
| 1999-12-31 | $2.33 Million | -71.62% |
| 1998-12-31 | $8.19 Million | +66.25% |
| 1997-12-31 | $4.93 Million | -16.15% |
| 1996-12-31 | $5.88 Million | -- |